tldrdailynews.com logo
Tag

Generic Drugs

All articles tagged with #generic drugs

Tariffs on generics may raise U.S. drug prices, Dr Reddy’s CEO warns
business1 month ago

Tariffs on generics may raise U.S. drug prices, Dr Reddy’s CEO warns

Dr. Reddy’s CEO Erez Israeli says Trump’s plan to tariff generic drugs would lift prices in the United States because the low-margin business cannot absorb added costs; moving generic manufacturing to the U.S. would likely take four to seven years. Despite onshoring aims, Indian manufacturers still dominate U.S. generic supply, and even with tariffs the cost gap makes relocation economically unviable for many firms. Dr. Reddy’s currently derives about 27% of its sales from the U.S. (down from 50%), with other Indian peers similarly benefiting from lower Indian production costs. Nomura also notes the tariffs could boost prices but won’t likely spur broad U.S. manufacturing migration.

via CNBC|
#business#dr-reddys#generic-drugs
Generic-Drug Tariffs Put U.S. Drug Onshoring to the Test
business1 month ago

Generic-Drug Tariffs Put U.S. Drug Onshoring to the Test

Trump’s proposal would slap tariffs on imported generic medicines with two years of no duties, then 100% for a year and 200% thereafter, to spur U.S. manufacturing. Industry warns the move could raise prices or force manufacturers to absorb costs, shift production, or exit markets, and that meaningful onshoring faces four-to-five-year timelines. Impacts will vary by company based on existing U.S. footprint and product mix, and much hinges on policy specifics like whether tariffs apply to finished drugs or imported active ingredients and how “domestic manufacturing” is defined.

via CNBC|
#business#generic-drugs#pharmaceutical-industry
Trump eyes escalating tariffs on generics to push U.S. production onshore
business1 month ago

Trump eyes escalating tariffs on generics to push U.S. production onshore

Trump outlined a phased tariff plan on imported generic drugs: zero tariffs for two years starting Aug 1, 2026, then a 100% levy in Aug 2028 and 200% a year later, while tariffs on patented drugs stay the same. The move aims to force generic manufacturers to relocate production to the U.S. as part of a broader push to lower drug prices and reshape supply chains, amid ongoing dynamics with India and China in pharma.

via CNBC|
#business#generic-drugs#onshoring
politics1 month ago

Trump proposes phased 100% tariffs on generic drugs starting 2028 to push U.S. production

Trump floated a plan to impose tariffs on generic drugs in a phased way: 0% for two years starting Aug 1, 2026, then 100% for one year, and 200% thereafter, meaning 100% tariffs would begin in August 2028 to push U.S. production. No formal order has been issued yet. The policy follows ongoing drug-pricing and trade actions, with exemptions for plants under construction and some trading partners; a White House spokesperson did not immediately respond.

via Politico|
#generic-drugs#pharmaceuticals#politics
U.S. Imposes Tariffs on Drugs, Furniture, and Lumber Amid Trade Tensions
business10 months ago

U.S. Imposes Tariffs on Drugs, Furniture, and Lumber Amid Trade Tensions

Drug stocks are rallying as President Trump's proposed 100% tariff on branded pharmaceutical imports mainly affects companies without U.S. manufacturing, leaving most Big Pharma and generics unaffected. The tariffs highlight supply chain vulnerabilities and long-term national security concerns, especially dependence on foreign countries like China for generics, but could also hinder biotech innovation and complicate import processes.

via Investor's Business Daily|
#business#drug-stocks#generic-drugs
Hims & Hers Expands Globally with ZAVA Acquisition and New Semaglutide Offerings
healthcare1 year ago

Hims & Hers Expands Globally with ZAVA Acquisition and New Semaglutide Offerings

Hims & Hers will offer generic semaglutide in Canada after Novo Nordisk's patent on Ozempic and Wegovy expired in January 2023 due to non-payment of maintenance fees, opening the market for more affordable weight loss treatments. The Canadian market for semaglutide is rapidly growing, and Hims aims to provide accessible, high-quality care, although the approval process for generics is still underway. Novo Nordisk's patent lapse was due to administrative oversight, and the company has stated that patent expirations are part of the normal lifecycle of pharmaceutical products.

via CNBC|
#canada#generic-drugs#healthcare
"Record High: US Drug Shortages Leave Patients Waiting for Lifesaving Medications"
health2 years ago

"Record High: US Drug Shortages Leave Patients Waiting for Lifesaving Medications"

The US is facing a record high of 323 active and ongoing drug shortages, affecting a wide range of medications including generic cancer drugs and ADHD medication. The shortages are attributed to various factors such as manufacturing delays, increased demand, and regulatory constraints. The American Society of Health-System Pharmacists (ASHP) is advocating for federal and regulatory changes to address the root causes of these shortages and improve supply chains.

via Ars Technica|
#adderall#ashp#drug-shortages
"Critical Drug Shortages in the U.S. Reach Record High"
health2 years ago

"Critical Drug Shortages in the U.S. Reach Record High"

Pharmacists warn of a growing number of drug shortages in the U.S., with 323 active medication shortages in the first three months of 2024, the highest since 2014. Shortages affect all drug classes, with particular concern for generic sterile injectable medications, including cancer chemotherapy drugs and emergency medications. Adderall, used for ADHD, remains in short supply despite efforts to increase production, with factors including increased demand during the pandemic and manufacturing constraints. Experts attribute shortages to demand outstripping supplies, manufacturing constraints, and disruptions in supply lines for raw materials.

via CBS News|
#adderall#ashp#drug-shortages